文献速递血管炎自身炎症与 IgG4 相关病其他结缔组织病

儿童Cogan综合征全外显子测序揭示单基因模拟病

Whole exome sequencing of paediatric patients with Cogan's syndrome to identify monogenic mimics.
PubMed 文献 · Rheumatology (Oxford) · 2026-01-01

本研究对10例临床诊断为儿童期起病Cogan综合征(pCS)的患者行全外显子测序,采用炎症与感音神经性聋虚拟基因面板、拷贝数变异分析及表型驱动变异 prioritization。结果3/10(30%)存在Class 4/5单基因变异贡献,另有2例携带意义未明变异。作者建议对疑似pCS儿童在贴标签前考虑基因检测。

要点

  • 10例临床诊断pCS患儿中3例(30%)检出Class 4/5单基因变异。
  • 检出变异涉及NLRP3、MYO7A及HBB,分别对应不同单基因病。
  • 建议疑似pCS患儿在确诊前行下一代测序基因检测。

核心结论

  • 儿童期起病Cogan综合征患者中至少30%存在替代性单基因病因,而非真正的pCS,对治疗和预后有影响。
  • 作者主张对表现为pCS的患者使用下一代测序进行基因检测。

研究设计与样本

  • 对10例临床诊断为儿童期起病Cogan综合征的患者行全外显子测序(WES)。
  • 分析采用内部流程,包括炎症与感音神经性聋虚拟基因面板、ExomeDepth拷贝数变异分析及Exomiser表型驱动变异 prioritization。
  • 遗传变异由多学科团队按美国医学遗传学与基因组学学会(ACMG)指南解读。

主要发现

  • 3/10(30%)基于Class 4/5变异判定有单基因贡献:de novo NLRP3 p.T915R(n=1)与Cryopyrin相关周期性综合征相关。
  • MYO7A p.K542Qfs*5(n=1)导致感音神经性聋。
  • HBB纯合p.E7V导致镰状细胞病,与听力损失和葡萄膜炎相关。
  • 另有2例携带可能的单基因贡献Class 3意义未明变异:ADGRV1复合杂合变异(n=1)与Usher综合征相关。
  • 新发ALPK1 p.H735P(n=1)与ROSAH综合征相关。

关键数值与推荐

  • 单基因贡献判定依据ACMG指南的Class 4/5变异。
  • 可能单基因贡献依据Class 3意义未明变异。

临床怎么用

  • 对具有Cogan综合征特征的儿童,在赋予该罕见诊断标签前应考虑基因筛查。
  • 对pCS表现患者推荐使用下一代测序进行基因检测,以识别可治疗或预后不同的单基因模拟病。

局限性

  • 样本量仅10例,结果需更大队列验证。
  • 2例为Class 3意义未明变异,单基因贡献仅为可能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Cogan's syndrome (CS) is a rare variable vessel vasculitis, describing sensorineural hearing loss (SNHL), inflammatory ocular disease and vestibular dysfunction. We hypothesized that within paediatric-onset (p)CS, a proportion would have monogenic disease, either autoinflammatory and/or associated with SNHL. METHODS: Whole exome sequencing (WES) was performed and analysed using an in-house pipeline incorporating virtual gene panels for inflammation and SNHL; copy number variant analysis (ExomeDepth); and phenotype-driven variant prioritization (Exomiser). Genetic variants were interpreted by a multi-disciplinary team according to American College of Medical Genetics and Genomics guidelines. RESULTS: Ten patients with a clinical diagnosis of pCS were enrolled. Three/10 (30%) had a monogenic contribution to the phenotype based on Class 4/5 variants: de novo NLRP3 p.T915R (n = 1) associated with Cryopyrin-associated periodic syndrome; MYO7A p.K542Qfs*5 (n = 1) causing SNHL; and HBB homozygous p.E7V causing sickle cell disease (associated with hearing loss and uveitis). A further two cases had possible monogenic contribution with the following rare variants of uncertain significance (class 3): ADGRV1 compound heterozygous variants (n = 1) associated with Usher syndrome; and a novel ALPK1 p.H735P (n = 1), associated with Retinal dystrophy Optic nerve oedema Splenomegaly Anhidrosis Headache (ROSAH) syndrome. CONCLUSIONS: In children presenting with features suggesting CS, genetic screening should be considered before conferring this rare diagnostic label since at least 30% had an alternative monogenic contribution to the phenotype rather than true pCS, with implications for treatment and prognosis. We thus advocate for genetic testing using next-generation sequencing for patients presenting with pCS.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. McLellan K, Price-Kuehne F, Burleigh A, et al. Whole exome sequencing of paediatric patients with Cogan's syndrome to identify monogenic mimics. Rheumatology (Oxford). 2026. PMID: 42640550. doi:10.1093/rheumatology/keag436

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。